Rallybio Corp has announced significant developments regarding its merger with Avenzo Therapeutics, Inc. The company expects the merger to close after trading on November 20, 2026, pending the satisfaction or waiver of any closing conditions. This merger is anticipated to create new opportunities for Rallybio, enhancing its position in the pharmaceutical preparations sector.
In conjunction with the merger, Rallybio has also confirmed a special cash distribution of $13.90 per share to stockholders and pre-funded warrant holders. This distribution is scheduled to be paid to those on record as of November 5, 2026, with actual payments expected to commence on November 30, 2026.
Background
Rallybio Corp, classified under the SIC code 2834 for Pharmaceutical Preparations, operates as an emerging growth company. The firm is listed on the Nasdaq under the ticker symbol RLYB. Its recent filings include a series of reports leading up to this significant announcement, including a merger agreement dated May 31, 2026.
What the Filing Says
The filing states, "Rallybio Corporation... anticipates the transactions contemplated by the Agreement and Plan of Merger... will close following the close of trading on November 20, 2026." It also outlines the details of the cash distribution, which will be payable to stockholders and warrant holders of record.
Impact
This merger and cash distribution will likely affect Rallybio’s stockholders and warrant holders significantly. The cash distribution is expected to incentivize current investors while attracting new ones, potentially increasing market interest in the company’s stock as the merger progresses.
What's Next
The next steps include the anticipated merger closing on November 20, 2026, and the distribution of cash payments beginning on November 30, 2026. Investors and stakeholders are advised to stay updated as further developments unfold.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





